|
ANAPC13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09479999510498E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18069999946557E-07 |
| Normal-vs-Stage2 |
1.73430999999002E-05 |
| Normal-vs-Stage3 |
1.10850000289986E-08 |
| Normal-vs-Stage4 |
1.31600000008447E-07 |
| Stage1-vs-Stage2 |
7.454000E-01 |
| Stage1-vs-Stage3 |
1.132140E-02 |
| Stage1-vs-Stage4 |
3.300000E-02 |
| Stage2-vs-Stage3 |
1.022990E-01 |
| Stage2-vs-Stage4 |
4.932000E-02 |
| Stage3-vs-Stage4 |
6.887600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03609999468901E-08 |
| Normal-vs-AfricanAmerican |
1.69110000003414E-06 |
| Normal-vs-Asian |
1.624610E-04 |
| Caucasian-vs-AfricanAmerican |
5.058600E-01 |
| Caucasian-vs-Asian |
1.488800E-01 |
| AfricanAmerican-vs-Asian |
1.050590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.96330000221823E-08 |
| Normal-vs-Female |
6.52520004695845E-09 |
| Male-vs-Female |
5.367800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.19529999734291E-08 |
| Normal-vs-Extreme_Weight |
4.40850000948956E-09 |
| Normal-vs-Obese |
3.54550000025711E-07 |
| Normal-vs-Extreme_Obese |
3.663200E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.943600E-01 |
| Normal_Weight-vs-Obese |
3.974000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.590000E-01 |
| Extreme_Weight-vs-Obese |
7.707000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.533800E-01 |
| Obese-vs-Extreme_Obese |
7.896000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.28160000015754E-07 |
| Normal-vs-Age(41-60Yrs) |
1.24290000003136E-06 |
| Normal-vs-Age(61-80Yrs) |
1.43289999865459E-08 |
| Normal-vs-Age(81-100Yrs) |
3.035800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.962400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.001560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.084200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.642400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.264600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.84224999999483E-05 |
| Normal-VS-Type2 PRCC |
6.65179999970178E-09 |
| Normal-VS-KIRP CIMP |
5.55977486271786E-12 |
| Normal-VS-Unclassified PRCC |
4.73819999902148E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.419500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.86950000036212E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.583560E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.822000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.827600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.618800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11570000407946E-08 |
| Normal-vs-N1 |
1.13310000049438E-07 |
| Normal-vs-N2 |
1.69080000000932E-06 |
| N0-vs-N1 |
5.798000E-01 |
| N0-vs-N2 |
3.942400E-02 |
| N1-vs-N2 |
8.204300E-02 |
|
|
